S. Ståhl

发表

Staphylococcal Surface Display of Metal-Binding Polyhistidyl Peptides

Patrik Samuelson, Stefan Ståhl, H. Wernérus, 2000, Applied and Environmental Microbiology.

Staphylococcal surface display and its applications.

M. Hansson, H. Wernérus, T. Nguyen, 2000, International journal of medical microbiology : IJMM.

Display of proteins on bacteria.

Patrik Samuelson, Stefan Ståhl, P. Nygren, 2002, Journal of biotechnology.

Vector engineering to improve a staphylococcal surface display system.

H. Wernérus, S. Ståhl, 2002, FEMS microbiology letters.

Optimization of electroporation‐mediated transformation: Staphylococcus carnosus as model organism

M. Uhlén, H. Wernérus, S. Ståhl, 2007, Journal of applied microbiology.

A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry.

John Löfblom, Nina Kronqvist, Stefan Ståhl, 2008, Protein engineering, design & selection : PEDS.

Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

Fredrik Y Frejd, J. Carlsson, S. Ståhl, 2010, FEBS letters.

Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules.

Fredrik Y Frejd, John Löfblom, Martin Nilsson, 2011, Protein engineering, design & selection : PEDS.

Surface display of a single-domain antibody library on Gram-positive bacteria

S. Muyldermans, U. Wernery, S. Ståhl, 2012, Cellular and Molecular Life Sciences.

Staphylococcal display for combinatorial protein engineering of a head‐to‐tail affibody dimer binding the Alzheimer amyloid‐β peptide

T. Härd, A. Johansson, S. Ståhl, 2013, Biotechnology journal.

Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support.

M. Uhlén, S. Ståhl, E. Hornes, 1989, Nucleic acids research.

Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins.

M. Uhlén, P. Nygren, J. Nilsson, 1997, Protein expression and purification.

The use of gene fusions to protein A and protein G in immunology and biotechnology.

P. Nygren, S. Ståhl, 1997, Pathologie-biologie.

Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain.

M. Uhlén, P. Nygren, K. Nord, 1997, Nature biotechnology.

Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain

M. Uhlén, P. Nygren, K. Nord, 1997, Nature Biotechnology.

A novel affinity gene fusion system allowing protein A-based recovery of non-immunoglobulin gene products.

M. Uhlén, R. Falk, S. Gräslund, 2002, Journal of biotechnology.

Construction and characterization of affibody-Fc chimeras produced in Escherichia coli.

M. Uhlén, M. Hansson, Jenny Rönnmark, 2002, Journal of immunological methods.

Affinity Proteomics for Systematic Protein Profiling of Chromosome 21 Gene Products in Human Tissues*

F. Pontén, M. Uhlén, A. Asplund, 2003, Molecular & Cellular Proteomics.

Selection and characterization of HER2/neu-binding affibody ligands.

G. Adams, J. Carlsson, E. Gunneriusson, 2004, Protein engineering, design & selection : PEDS.

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.

G. Adams, J. Carlsson, S. Ståhl, 2005, Cancer biotherapy & radiopharmaceuticals.

Tumor imaging using a picomolar affinity HER2 binding affibody molecule.

J. Carlsson, I. Höidén-Guthenberg, S. Ståhl, 2006, Cancer research.

Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.

H. Brismar, G. Adams, J. Carlsson, 2007, Protein engineering, design & selection : PEDS.

Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.

S. Lindström, E. Gunneriusson, S. Ståhl, 2007, Journal of biotechnology.

Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides

S. Lindström, E. Gunneriusson, S. Ståhl, 2007 .

Generation of Affibody® ligands binding interleukin‐2 receptor α/CD25

S. Ståhl, N. Herne, C. Grönwall, 2008, Biotechnology and applied biochemistry.

Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab.

S. Ståhl, J. Löfblom, V. Tolmachev, 2018, Molecular pharmaceutics.

Directed immobilization of recombinant staphylococci on cotton fibers by functional display of a fungal cellulose-binding domain.

H. Wernérus, T. Teeri, J. Lehtiö, 2001, FEMS microbiology letters.

Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding.

M. Uhlén, H. Binz, S. Ståhl, 1997, Journal of immunological methods.

Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli

Per Jonasson, Stefan Ståhl, P. Jonasson, 2002, Biotechnology and applied biochemistry.

Bacterial surface display: trends and progress.

M. Uhlén, S. Ståhl, M Uhlén, 1997, Trends in biotechnology.

Generation of Metal-Binding Staphylococci through Surface Display of Combinatorially Engineered Cellulose-Binding Domains

Tuula Teeri, Stefan Ståhl, H. Wernérus, 2001, Applied and Environmental Microbiology.

Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity

Fredrik Y Frejd, E. Gunneriusson, S. Ståhl, 2014, Scientific Reports.

Engineered affinity proteins for tumour‐targeting applications

S. Ståhl, M. Friedman, 2009, Biotechnology and applied biochemistry.

Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model

L. Claesson‐Welsh, S. Ståhl, J. Löfblom, 2018, Theranostics.

The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein.

T. Nguyen, J. Bonnefoy, S. Ståhl, 1999, Vaccine.

Subunit Vaccine Candidates Engineered from the Central Conserved Region of the RSV G Protein Aimed for Parenteral or Mucosal Delivery

S. Ståhl, T. Nguyen, C. Libon, 2013 .

Achieving directed immunostimulating complexes incorporation

S. Ståhl, M. Wikman, M. Friedman, 2006, Expert review of vaccines.

General strategies for efficient adjuvant incorporation of recombinant subunit immunogens.

S. Ståhl, M. Wikman, M. Friedman, 2005, Vaccine.

In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation.

S. Ståhl, M. Wikman, A. Lundén, 2001, Journal of immunological methods.

Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen.

S. Ståhl, P. Liljeström, U. Power, 2000, FEMS immunology and medical microbiology.

Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporation.

H. Wernérus, S. Ståhl, C. Andersson, 2000, Journal of immunological methods.

Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides.

T. Nguyen, J. Bonnefoy, P. Samuelson, 2000, Vaccine.

Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate.

T. Nguyen, J. Bonnefoy, S. Ståhl, 2000, Vaccine.

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines.

S. Ståhl, S. Liljeqvist, S. Ståhl, 1999, Journal of biotechnology.

General expression vectors for production of hydrophobically tagged immunogens for direct iscom incorporation.

A. Sjölander, S. Ståhl, M. Murby, 1999, Journal of immunological methods.

Limited genetic diversity of Plasmodium falciparum in field isolates from Honduras.

G. Snounou, S. Ståhl, D. Mattei, 1999, The American journal of tropical medicine and hygiene.

188Re-ZHER2:V2, a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment

M. Lubberink, S. Strand, S. Ståhl, 2014, The Journal of Nuclear Medicine.

Autotransporter-Mediated Display of a Naïve Affibody Library on the Outer Membrane of Escherichia coli.

S. Ståhl, J. Löfblom, Jonas Persson, 2018, Biotechnology journal.

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

S. Ståhl, J. Löfblom, V. Tolmachev, 2017, Scientific Reports.

Cell-surface display of heterologous epitopes on Staphylococcus xylosus as a potential delivery system for oral vaccination.

M. Uhlén, M. Hansson, T. Bächi, 1993, Gene.

Expression of recombinant proteins on the surface of the coagulase-negative bacterium Staphylococcus xylosus

M. Uhlén, M. Hansson, T. Bächi, 1992, Journal of bacteriology.

Syddansk Universitet The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated

Tolmachev, S. Ståhl, A. Orlova, 2017 .

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111

S. Ståhl, J. Löfblom, V. Tolmachev, 2019, Scientific Reports.

Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator

S. Ståhl, J. Löfblom, V. Tolmachev, 2016, International journal of oncology.

PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules

S. Ståhl, J. Löfblom, V. Tolmachev, 2016, International journal of oncology.

Affibody‑mediated imaging of EGFR expression in prostate cancer using radiocobalt‑labeled DOTA‑ZEGFR:2377.

S. Ståhl, J. Löfblom, V. Tolmachev, 2018, Oncology reports.

Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene.

S. Ståhl, M. Wikman, C. Fernández, 2005, Vaccine.

Approaches to Solid Phase DNA Sequencing

M. Uhlén, T. Moks, S. Ståhl, 1988 .

Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties

S. Hosseinimehr, S. Ståhl, V. Tolmachev, 2011, The Journal of Nuclear Medicine.

Generation of tumour‐necrosis‐factor‐α‐specific affibody 1 molecules capable of blocking receptor binding in vitro

Fredrik Y Frejd, S. Ståhl, A. Jonsson, 2009, Biotechnology and applied biochemistry.

Differential induction of immunoglobulin G subclasses by immunization with DNA vectors containing or lacking a signal sequence.

S. Ståhl, S. Liljeqvist, P. Perlmann, 1998, Immunology letters.

Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice.

S. Ståhl, S. Liljeqvist, I. Andersson, 1997, FEMS immunology and medical microbiology.

Development of Non-Pathogenic Staphylococci as Vaccine Delivery Vehicles

M. Uhlén, M. Hansson, H. Binz, 1997 .

Engineered bacterial receptors in immunology.

M. Uhlén, A. Sjölander, P. Nygren, 1993, Current opinion in immunology.

Genetic Strategies for Protein Purification

M. Uhlén, P. Nygren, S. Ståhl, 1991 .

Single-step trypsin cleavage of a fusion protein to obtain human insulin and its C peptide.

M. Uhlén, T. Moks, J. Nilsson, 1996, European journal of biochemistry.

Fluorescence-Activated Cell Sorting of Specific Affibody-Displaying Staphylococci

H. Wernérus, P. Samuelson, S. Ståhl, 2003, Applied and Environmental Microbiology.

Engineered Cellulose-Binding Domains through Surface Display of Combinatorially Generation of Metal-Binding Staphylococci

H. Wernérus, T. Teeri, J. Lehtiö, 2001 .

Comparative Immunization Study Using RNA and DNA Constructs Encoding a Part of the Plasmodium falciparum Antigen Pf332

S. Ståhl, S. Liljeqvist, P. Liljeström, 2001, Scandinavian Journal of Immunology.

Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re.

S. Ståhl, J. Löfblom, V. Tolmachev, 2014, European journal of medicinal chemistry.

Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.

S. Ståhl, P. Perlmann, N. Ahlborg, 1996, Experimental parasitology.

Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity.

M. Hansson, S. Ståhl, S. Liljeqvist, 1995, FEMS Immunology & Medical Microbiology.

Cell surface display of recombinant proteins on Staphylococcus carnosus

M. Uhlén, M. Hansson, T. Bächi, 1995, Journal of bacteriology.

Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules

S. Ståhl, J. Löfblom, A. Orlova, 2022, Biomedicines.

Staphylococcus carnosus: from starter culture to protein engineering platform

S. Ståhl, J. Löfblom, F. Götz, 2017, Applied Microbiology and Biotechnology.

Biotechnological applications for surface‐engineered bacteria

H. Wernérus, S. Ståhl, 2004, Biotechnology and applied biochemistry.

Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Aβ-Affibodies

S. Ståhl, J. Löfblom, H. Lindberg, 2022, Pharmaceutical Research.

Simplified characterization through site-specific protease-mediated release of affinity proteins selected by staphylococcal display.

H. Wernérus, S. Ståhl, J. Löfblom, 2008, FEMS microbiology letters.

Engineering of a Staphylococcus carnosus surface display system by substitution or deletion of a Staphylococcus hyicus lipase propeptide.

P. Samuelson, S. Ståhl, A. Robert, 1999, FEMS microbiology letters.

Detection and isolation of recombinant proteins based on binding affinity of reporter: protein A.

M. Uhlén, P. Nygren, S. Ståhl, 1997, Methods in molecular biology.

Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus

M. Hansson, H. Binz, T. Nguyen, 1997, Applied and environmental microbiology.

Surface display on staphylococci: a comparative study

M. Uhlén, T. Bächi, H. Binz, 1996, FEBS letters.

A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery.

T. Nguyen, J. Bonnefoy, P. Samuelson, 1999, FEMS immunology and medical microbiology.

Characterization of immune responses to experimental polyvalent subunit vaccines assembled in iscoms.

A. Sjölander, S. Ståhl, N. Ahlborg, 1998, Molecular immunology.

Single-vector three-frame expression systems for affinity-tagged proteins.

M. Uhlén, R. Falk, S. Gräslund, 2002, FEMS microbiology letters.

Recombinant technology as an alternative to chemical peptide synthesis: expression and characterization of HIV-1 Rev recombinant peptides.

P. Lepage, S. Ståhl, S. Humbert, 1993, Analytical biochemistry.

Solid-phase gene assembly of constructs derived from the Plasmodium falciparum malaria blood-stage antigen Ag332.

M. Uhlén, J. Lundeberg, M. Hansson, 1993, BioTechniques.

Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum‐reactive antibodies which inhibit parasite growth but not cytoadherence

M. Uhlén, M. Hansson, S. Ståhl, 1995, Parasite immunology.

Immunogenicity and antigenicity in rabbits of a repeated sequence of Plasmodium falciparum antigen Pf155/RESA fused to two immunoglobulin G-binding domains of staphylococcal protein A

M. Uhlén, A. Sjölander, P. Nygren, 1990, Infection and immunity.

Strategies for gene fusions.

M. Uhlén, P. Nygren, S. Ståhl, 1997, Methods in molecular biology.

Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen.

S. Ståhl, P. Liljeström, U. Power, 2000, FEMS immunology and medical microbiology.

Affinity proteins and their generation

S. Ståhl, J. Löfblom, N. Kronqvist, 2013 .

Expression of Ciliary Tektins in Brain and Sensory Development

S. Ståhl, R. Linck, M. Larsson, 1998, The Journal of Neuroscience.

Engineered affinity proteins--generation and applications.

Stefan Ståhl, S. Ståhl, C. Grönwall, 2009, Journal of biotechnology.

Epitope mapping of antibodies using bacterial surface display

M. Uhlén, Johan Rockberg, S. Ståhl, 2008, Nature Methods.

Affibody Molecules in Biotechnological and Medical Applications.

Stefan Ståhl, Torbjörn Gräslund, Amelie Eriksson Karlström, 2017, Trends in biotechnology.

Approaches for systematic proteome exploration.

R. Falk, S. Hober, M. Ramström, 2007, Biomolecular engineering.

Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds

Fredrik Y Frejd, S. Ståhl, J. Löfblom, 2016, mAbs.

Genetic engineering applied to the development of vaccines.

S. Ståhl, P. Ashton‐Rickardt, K. Murray, 1989, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Solid phase in vitro mutagenesis using plasmid DNA template.

M. Uhlén, S. Ståhl, E. Hornes, 1990, Nucleic acids research.

Solid phase DNA sequencing using the biotin-avidin system.

M. Uhlén, A. Olsson, T. Moks, 1988, Nucleic acids research.

Multiple affinity domains for the detection, purification and immobilization of recombinant proteins

Mathias Uhlén, Stefan Ståhl, M. Uhlén, 1996, Journal of molecular recognition : JMR.

Engineering of staphylococcal surfaces for biotechnological applications.

Janne Lehtiö, Patrik Samuelson, Stefan Ståhl, 2002, Journal of biotechnology.

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model

Fredrik Y Frejd, T. Wisniewski, T. Härd, 2019, Front. Aging Neurosci..

Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β

T. Härd, E. Wahlberg, M. Sandgren, 2017, Scientific Reports.

Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu

N. Habib, S. Ståhl, S. S. Hong, 2007, Cancer Gene Therapy.

Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation

T. Härd, S. Ståhl, A. Jonsson, 2008, Proceedings of the National Academy of Sciences.

Semi-automated solid-phase DNA sequencing.

M. Uhlén, J. Lundeberg, B. Pettersson, 1992, Trends in biotechnology.

Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.

E. Johansson, I. Höidén-Guthenberg, S. Ståhl, 2008, Journal of molecular biology.

Specific binding of proinsulin C-peptide to human cell membranes.

G Kratz, M. Uhlén, H. Jörnvall, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Design and evaluation of radiolabeled tracers for tumor imaging

S. Ståhl, H. Wållberg, 2013, Biotechnology and applied biochemistry.

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice

G. Adams, J. Carlsson, S. Ståhl, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Non-immunoglobulin based protein scaffolds.

S. Ståhl, J. Löfblom, F. Frejd, 2011, Current opinion in biotechnology.

General expression vectors for Staphylococcus carnosus enabled efficient production of the outer membrane protein A of Klebsiella pneumoniae.

M. Hansson, P. Samuelson, S. Ståhl, 2002, FEMS microbiology letters.

Chromosomal sequencing using a PCR-based biotin-capture method allowed isolation of the complete gene for the outer membrane protein A of Klebsiella pneumoniae.

M. Uhlén, F. Sterky, H. Binz, 1998, Gene.

In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct

S. Ståhl, J. Löfblom, V. Tolmachev, 2017, Scientific Reports.

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.

M. Uhlén, H. Binz, T. Nguyen, 1997, Virology.

The serum albumin-binding region of streptococcal protein G: a bacterial fusion partner with carrier-related properties.

M. Uhlén, A. Sjölander, P. Nygren, 1997, Journal of immunological methods.

Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signaling

S. Ståhl, J. Löfblom, Filippa Fleetwood, 2015, Cellular and Molecular Life Sciences.

Single–Step Recovery of a Secreted Recombinant Protein by Expanded Bed Adsorption

M. Uhlén, M. Hansson, T. Moks, 1994, Bio/Technology.

Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry

S. Ståhl, V. Tolmachev, F. Frejd, 2009, Journal of Nuclear Medicine.

Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.

J. Carlsson, S. Ståhl, V. Tolmachev, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.

M. Hansson, A. Sjölander, P. Nygren, 1991, Vaccine.

Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake

Jonas Grafström, H. Ahlzén, S. Stone-Elander, 2016, EJNMMI Research.

Integrated bioprocess for production of human proinsulin C-peptide via heat release of an intracellular heptameric fusion protein.

M. Uhlén, H. Jörnvall, J. Wahren, 2000, Journal of biotechnology.

Generation of an anti-idiotypic affibody-based masking domain for conditional activation of EGFR-targeting.

S. Ståhl, J. Löfblom, C. D. Leitao, 2022, New biotechnology.

Selection and characterization of an HIV‐1 gp120‐binding affibody ligand

S. Ståhl, P. Henning, L. Lindholm, 2006, Biotechnology and applied biochemistry.

Engineering streptococcal protein G for increased alkaline stability.

Sophia Hober, Stefan Ståhl, S. Hober, 2002, Protein engineering.

Upstream strategies to minimize proteolytic degradation upon recombinant production in Escherichia coli.

M. Uhlén, S. Ståhl, M Uhlén, 1996, Protein expression and purification.

Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber

S. Ståhl, P. Henning, L. Lindholm, 2009, Gene Therapy.

Engineering proteins to facilitate bioprocessing.

M. Uhlén, P. Nygren, S. Ståhl, 1994, Trends in biotechnology.

Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus.

M. Uhlén, H. Binz, S. Ståhl, 1995, European journal of biochemistry.

An Affibody Molecule Is Actively Transported into the Cerebrospinal Fluid via Binding to the Transferrin Receptor

H. Tegel, S. Ståhl, J. Löfblom, 2020, International journal of molecular sciences.

A truncated and dimeric format of an Affibody library on bacteria enables FACS‐mediated isolation of amyloid‐beta aggregation inhibitors with subnanomolar affinity

T. Härd, S. Ståhl, J. Löfblom, 2015, Biotechnology journal.

Mammalian cell production of a respiratory syncytial virus (RSV) candidate vaccine recovered using a product‐specific affinity column

M. Hansson, P. Nygren, S. Ståhl, 2001, Biotechnology and applied biochemistry.

Engineering and characterization of a bispecific HER2 × EGFR‐binding affibody molecule

Fredrik Y Frejd, Helene Andersson-Svahn, Sara Lindström, 2009, Biotechnology and applied biochemistry.

HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers

S. Ståhl, J. Löfblom, V. Tolmachev, 2021, Cancers.

Integrated production of human insulin and its C-peptide.

M. Uhlén, J. Nilsson, P. Jonasson, 1996, Journal of biotechnology.

Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression.

S. Ståhl, J. Löfblom, V. Tolmachev, 2017, International journal of oncology.

Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2.

S. Ståhl, F. Frejd, L. Gedda, 2012, Bioconjugate chemistry.

Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules

S. Hosseinimehr, S. Ståhl, V. Tolmachev, 2012, Amino Acids.

Cellular Effects of HER3-Specific Affibody Molecules

I. Höidén-Guthenberg, S. Ståhl, J. Löfblom, 2012, PloS one.

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

I. Höidén-Guthenberg, S. Ståhl, J. Löfblom, 2013, PloS one.

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.

Hjalmar Brismar, Jörgen Carlsson, Bengt Glimelius, 2007, Nuclear medicine and biology.

Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus

S. Ståhl, V. Tolmachev, A. Orlova, 2012, Tumor Biology.

Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules

S. Hosseinimehr, S. Ståhl, V. Tolmachev, 2011, Amino Acids.

Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand.

Mathias Uhlén, Vladimir Tolmachev, Stefan Ståhl, 2011, Protein expression and purification.

Evaluating the therapeutic potential of a dimeric HER 3-binding affibody construct in comparison with a monoclonal antibody , seribantumab MANUSCRIPT

S. Ståhl, V. Tolmachev, F. Frejd, 2017 .

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

S. Ståhl, J. Löfblom, V. Tolmachev, 2017, Scientific Reports.

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model

P. Jonasson, S. Ståhl, J. Löfblom, 2020, Pharmaceutics.

Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

S. Ståhl, J. Löfblom, V. Tolmachev, 2020, International journal of molecular sciences.

Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs

S. Ståhl, J. Löfblom, V. Tolmachev, 2018, Cells.

Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin‐binding domain allows for affinity purification and in vivo half‐life extension

Fredrik Y Frejd, S. Ståhl, J. Löfblom, 2014, Biotechnology journal.

Affibody-mediated transferrin depletion for proteomics applications.

S. Hober, M. Ramström, I. Höidén-Guthenberg, 2007, Biotechnology journal.

Plasmodium falciparum: the immune response in rabbits to the clustered asparagine-rich protein (CARP) after immunization in Freund's adjuvant or immunostimulating complexes (ISCOMs).

M. Uhlén, M. Hansson, A. Sjölander, 1993, Experimental parasitology.

A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.

M. Uhlén, A. Sjölander, P. Nygren, 1989, Journal of immunological methods.

Bacterial Expression Systems Based on a Protein A and Protein G Designed for the Production of Immunogens: Applications to Plasmodium falciparum Malaria Antigens

Stefan Ståhl, A. Sjölander, S. Ståhl, 1993 .

Gene fragment polymerization gives increased yields of recombinant human proinsulin C-peptide.

M. Uhlén, J. Wahren, P. Nygren, 1998, Gene.

A general strategy for polymerization, assembly and expression of epitope-carrying peptides applied to the Plasmodium falciparum antigen Pf155/RESA.

M. Uhlén, M. Hansson, A. Sjölander, 1990, Gene.

B- and T-cell responses in congenic mice to repeat sequences of the malaria antigen Pf332: effects of the number of repeats.

M. Hansson, S. Ståhl, I. Andersson, 1994, Immunology letters.

Surface display of functional fibronectin‐binding domains on Staphylococcus carnosus

M. Uhlén, S. Ståhl, A. Robert, 1999, FEBS letters.

Affibody-mediated PET imaging of HER3 expression in malignant tumours

S. Ståhl, J. Löfblom, V. Tolmachev, 2015, Scientific Reports.

Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors.

S. Ståhl, J. Löfblom, V. Tolmachev, 2015, Oncology reports.

Imaging of HER3-expressing xenografts in mice using a 99mTc(CO)3-HEHEHE-ZHER3:08699 affibody molecule

S. Ståhl, J. Löfblom, V. Tolmachev, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations.

S. Ståhl, J. Mattsson, M. Wikman, 2007, Vaccine.

Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms.

S. Ståhl, J. Mattsson, M. Wikman, 2005, Veterinary parasitology.

Surface display of a single-domain antibody library on Gram-positive bacteria

S. Muyldermans, U. Wernery, S. Ståhl, 2013, Cellular and Molecular Life Sciences.

Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69

O. Korsgren, P. Nygren, S. Ståhl, 2021, Scientific Reports.

Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules

S. Ståhl, J. Löfblom, V. Tolmachev, 2020, International journal of molecular sciences.

Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

S. Ståhl, J. Löfblom, V. Tolmachev, 2019, Scientific Reports.

Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers

S. Ståhl, J. Löfblom, V. Tolmachev, 2019, International journal of molecular sciences.

HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically 11C-Labeled Sel-Tagged Affibody Molecule

Jonas Grafström, S. Stone-Elander, Elias S. J. Arnér, 2012, The Journal of Nuclear Medicine.

Exploring epitopes of antibodies toward the human tryptophanyl-tRNA synthetase.

M. Uhlén, Johan Rockberg, S. Ståhl, 2010, New biotechnology.

Staphylococcal Surface Display of Immunoglobulin A (IgA)- and IgE-Specific In Vitro-Selected Binding Proteins (Affibodies) Based on Staphylococcus aureus Protein A

Patrik Samuelson, Stefan Ståhl, H. Grönlund, 1999, Applied and Environmental Microbiology.

an obtaining process derived peptide respiratory syncytial virus, polypeptide, and expressing the bacterium, and their applications as medicaments

M. Uhlén, H. Binz, P. Nygren, 1994 .

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein.

M. Uhlén, M. Hansson, P. Nygren, 1999, Immunotechnology : an international journal of immunological engineering.

In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells.

J. Carlsson, S. Ståhl, V. Tolmachev, 2008, Oncology reports.

Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity.

S. Ståhl, J. Löfblom, V. Tolmachev, 2023, Journal of Controlled Release.

Flow‐cytometric screening of aggregation‐inhibitors using a fluorescence‐assisted intracellular method

M. Uhlén, S. Ståhl, J. Löfblom, 2017, Biotechnology journal.

Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake

S. Ståhl, J. Löfblom, V. Tolmachev, 2019, Scientific Reports.

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Fredrik Y Frejd, I. Höidén-Guthenberg, S. Ståhl, 2013, PloS one.

Affibody Molecules Intended for Receptor-Mediated Transcytosis via the Transferrin Receptor

S. Ståhl, J. Löfblom, H. Lindberg, 2023, Pharmaceuticals.

Feasibility of radionuclide imaging of HER3-expressing tumours using technetium-99m labeled affibody molecules

S. Ståhl, J. Löfblom, N. Kronqvist, 2013 .

Staphylococcal surface display in combinatorial protein engineering and epitope mapping of antibodies.

M. Uhlén, Johan Rockberg, S. Ståhl, 2010, Recent patents on biotechnology.

Engineered affinity proteins for tumour‐targeting applications

S. Ståhl, M. Friedman, 2009, Biotechnology and applied biochemistry.

Flow cytometric quantification of surface-displayed recombinant receptors on staphylococci.

M. Uhlén, H. Binz, P. Samuelson, 1997, BioTechniques.

Non-immunoglobulin based protein scaffolds.

Fredrik Y Frejd, S. Ståhl, F. Frejd, 2011, Current opinion in biotechnology.

Affibody Molecules in Biotechnological and Medical Applications.

Fredrik Y Frejd, P. Nygren, S. Ståhl, 2017, Trends in biotechnology.

Evaluation of Staphylococcal Cell Surface Display and Flow Cytometry for Postselectional Characterization of Affinity Proteins in Combinatorial Protein Engineering Applications

H. Wernérus, S. Ståhl, J. Sandberg, 2007, Applied and Environmental Microbiology.

Contributory presentations/posters

Diederichs, Bosco K. Ho, Hironori K. Nakamura, 1999, Journal of Biosciences.

Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signaling

S. Ståhl, Filippa Fleetwood, E. Gordon, 2016, Cellular and Molecular Life Sciences.